Acquirer(s)

  • Healthscope Limited
  • Ironbridge Capital
  • Archer Capital

Target(s)

  • Symbion Health Limited

Summary

A consortium comprising Healthscope Limited, Ironbridge Capital and Archer Capital proposed to acquire Symbion Health Limited. Healthscope proposed to acquire Symbion Health's pathology, medical centres and diagnostic imaging businesses. Ironbridge Capital and Archer Capital proposed to acquire Symbion Health's pharmacy distribution and consumer businesses.

Market definition

Please see detailed Public Competition Assessment below.

Competition analysis

Please see detailed Public Competition Assessment below.

Timeline

Date Event

ACCC commenced review under the Merger Review Process Guidelines.

Closing date for submissions from interested parties.

Former proposed date for announcement of ACCC's findings, amended to allow for further market inquiries.

ACCC published a Statement of Issues outlining preliminary competition concerns. New round of market inquiries commenced.

Closing date for submissions relating to Statement of Issues.

ACCC requested further information from Healthscope, response expected by 20 July 2007. ACCC expects to announce findings within three weeks of Healthscope's response. ACCC timeline suspended.

ACCC received further information from Healthscope. ACCC timeline recommenced.

Draft 87B undertaking proffered by Healthscope. ACCC commenced market inquiries.

Closing date for submissions relating to draft 87B undertaking proferred by Healthscope on 26 July 2007.

ACCC announced it would not oppose the proposed acquisition, subject to the ACCC accepting the 87B proferred by Healthscope.

Healthscope submitted a revised 87B undertaking for ACCC consideration.

ACCC consented to withdrawal by Healthscope of 87B undertaking accepted by the ACCC on 15 August 2007. ACCC accepted replacement 87B undertaking proffered by Healthscope. ACCC also accepted 87B undertaking proferred by Symbion.

Healthscope announced it had decided not to proceed with the proposed acquisition.

Healthscope sought consent to withdraw 87B undertaking.

Symbion sought consent to withdraw 87B undertaking.

ACCC consented to withdrawal by Healthscope and Symbion of 87B undertakings accepted on 25 October 2007.